PCI Pharma Services Applies to Import Controlled Drugs
Published Date: 6/18/2025
Notice
Summary
AndersonBrecon, Inc., also known as PCI Pharma Services, wants to get official approval to import certain controlled substances. This means they’ll be able to bring in specific drugs that need special handling. If approved, it could affect companies and regulators watching drug imports, with no immediate cost changes announced.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Company Applied To Import Controlled Drugs
AndersonBrecon, Inc. (doing business as PCI Pharma Services) applied to be registered as an importer of basic classes of controlled substances. If approved, they would be allowed to bring in specific drugs that require special handling. The notice says this could affect companies and regulators watching drug imports, and that no immediate cost changes were announced.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in